Locus Pharmaceuticals logo — company profile

Locus Pharmaceuticals

Founded 1998 6 employees Debt Financing Total: $139.63M Biotechnology, Pharmaceutical

General Information

Company Name Locus Pharmaceuticals
Founded Year 1998
Employees 6
Industries Biotechnology, Pharmaceutical
Funding Stage Debt Financing
Social

Get notified when Locus Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Locus Pharmaceuticals

Locus Pharmaceuticals is a pioneering biotechnology company specializing in drug discovery and development. Established in 1998, the company leverages its patented drug design technology to create innovative therapeutics. It has formed strategic collaborations with pharmaceutical partners and developed a promising pipeline of early-stage drug candidates targeting cancer and inflammatory conditions. In 08 July 2010, Locus Pharmaceuticals secured a significant $1.68M debt financing investment. Having demonstrated its commitment to advancing breakthrough treatments, the company presents a compelling opportunity for venture capital investment in the biotechnology and pharmaceutical sectors.

Taxonomy: drug discovery, drug development, therapeutics, patented technology, collaboration projects, pharmaceutical partners, pipeline, early-stage assets, cancer, inflammatory indications, innovation, technology, pharmaceutical industry, startup

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 08 Jul 2010
Series E •••••• 3
Investor Investor
•••• ••••
14 Feb 2007
Series E •••••• - 13 Nov 2006
Series C •••••• 6
Investor Investor Investor Investor
•••• ••••
07 Nov 2001
Series B •••••• 1
Investor
28 Nov 2000

Locus Pharmaceuticals Alternatives & Competitors

Locus Pharmaceuticals vs

Utilizing advanced AI to discover new drug candidates by scanning extensive libraries of chemical co...

Series A
2-10 employees
AI, Health Care
Locus Pharmaceuticals vs

Delivering the future of medicines

Series C
12 employees
Biotechnology, Pharmaceutical
Locus Pharmaceuticals vs
Atomwise
Atomwise United States

Better Medicines Faster

Grant
15 employees
AI, Biotechnology

FAQ About Locus Pharmaceuticals

Locus Pharmaceuticals, Inc. is a privately held drug discovery and development biotechnology company creating novel therapeutics using its patented drug design technology. Locus was founded in 2000 based on its platform technology, entered into multiple drug discovery collaboration projects with pha...
Locus Pharmaceuticals was founded in 1998.
Locus Pharmaceuticals operates in the following industries: Biotechnology, Pharmaceutical.
Locus Pharmaceuticals has approximately 6 employees.
Locus Pharmaceuticals has completed 5 funding rounds, raising a total of $139.63M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Locus Pharmaceuticals include X-37, Alivexis, Inc, Atomwise, New England Discovery Partners (NEDP), Disruptive Pharma AB. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Locus Pharmaceuticals and X-37 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Locus Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy